IP Library Assignment 013729/0401
Patent Assignment
Reel/Frame 013729/0401

Assignment of Assignor's Interest

Recorded: 2003-02-04 Pages: 3
Assignor
Assignee
AMYLIN PHARMACEUTICALS, INC.
9373 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (3)
Treatment of Hibernating Myocardium and Diabetic Cardiomyopathy with a Glp-1 Peptide
Patent: 6,894,024 →
Application: 09/982,978 →
Publication: US 2002/0146405
Treatment of hibernating myocardium with a glp-1 peptide
Application: 60/241,834 →
Treatment of hibernating myocardium with a glp-1 peptide
Application: 60/242,139 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 18, 2001
From: RESTORAGEN, INC., F/K/A BIONEBRASKA, INC.
To: MEDTRONIC INTERNATIONAL, LTD.
Reel/Frame 012350/0779 →
Assignment of Assignor's Interest Jan 14, 2002
From: COOLIDGE, THOMAS R.; EHLERS, MARIO
To: BIONEBRASKA, INC.
Reel/Frame 012470/0642 →
Change of Name Oct 25, 2012
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 029198/0340 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →